2023
DOI: 10.2147/opth.s379856
|View full text |Cite
|
Sign up to set email alerts
|

Intraocular Implantable Collamer Lens with a Central Hole Implantation: Safety, Efficacy, and Patient Outcomes

Abstract: This review summarizes the available literature and provides updates on the efficacy, safety, and patient outcomes of phakic intraocular lens implantation using implantable collamer lens (ICL), with a focus on newer models with a central port (EVO/EVO+ Visian Implantable Collamer Lens, STAAR Surgical Inc.). All studies included in this review were identified from the PubMed database and were reviewed for relevancy of their topic. Data on hole-ICL implantation performed between October 2018 and October 2022 in … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2

Citation Types

0
10
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
6
2

Relationship

0
8

Authors

Journals

citations
Cited by 11 publications
(11 citation statements)
references
References 98 publications
0
10
0
Order By: Relevance
“…The V4c ICL model used in our research incorporates a central port in the lens design allowing the ow of aqueous humor. The consistent intraocular pressure indicates that having a central hole in the ICL may help regulate IOP without the necessity of peripheral iridotomy 12 .…”
Section: Discussionmentioning
confidence: 91%
“…The V4c ICL model used in our research incorporates a central port in the lens design allowing the ow of aqueous humor. The consistent intraocular pressure indicates that having a central hole in the ICL may help regulate IOP without the necessity of peripheral iridotomy 12 .…”
Section: Discussionmentioning
confidence: 91%
“…Old age (> 40 years), high myopia (< −12.0D), and low vault (< 230 μm) are risk factors for cataract progression ( 27 ). In long-term follow-up studies of patients with central-hole ICLs over 5 years, the incidence of anterior subcapsular cataracts was 0.53%, whereas that of nuclear cataracts was 0.08% ( 28 ). Notably, nuclear cataract occurrence is associated with age and not influenced by ICL implantation ( 18 ).…”
Section: Discussionmentioning
confidence: 99%
“…More than 2 million of these pIOLs (Visian and EVO) have been implanted worldwide to date. 1 In the United States, ICL use has grown rapidly since 2022, when the Food and Drug Administration approved the EVO lens, its toric equivalent, and a version with a larger optic diameter (EVO+). More than 100 scientific papers analyzing the performance of EVO and EVO+ lenses have been published.…”
Section: Introductionmentioning
confidence: 99%